Sfoglia per AUTORE
PIGA A
Collezione AOU San Luigi di Orbassano

  

Items : 28

Overall and complication-free survival in a large cohort of patients with ?-thalassemia major followed over 50?years. in American journal of hematology / Am J Hematol. 2023 Mar;98(3):381-387. doi: 10.1002/ajh.26798. Epub 2023 Jan 1.
2023
AOU San Luigi di Orbassano

Forni GL; Gianesin B; Musallam KM; Longo F; Rosso R; Lisi R; Gamberini MR; Pinto VM; Graziadei G; Vitucci A; Bonetti F; Musto P; Piga A; Cappellini MD; Borgna-Pignatti C;

2023
ASL Torino 4
AOU San Luigi di Orbassano

Piga A; Maggio A; Cappellini MD; Mazzi F; Spadola V; Graziadei G; Quota A; Rigano P; Longo F; Gianesin B; Piel FB; Pinto VM; De Franceschi L; Forni GL;

Mortality in ?-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization. in Blood / Blood. 2022 Mar 31;139(13):2080-2083. doi: 10.1182/blood.2021014862.
2022
ASL Torino 4
AOU San Luigi di Orbassano

Cappellini MD; Piga A; Merella P; Tartaglione I; Miceli R; Casale M; Longo F; Pasanisi A; Casu G; Barella S; Origa R; Giuditta M; Graziadei G; Derchi G; Musallam KM; Pinto VM; Gianesin B; Forni GL;

Tricuspid-valve regurgitant jet velocity as a risk factor for death in ?-thalassemia. in Haematologica / Haematologica. 2022 Jul 1;107(7):1714-1718. doi: 10.3324/haematol.2021.280389.
2022
ASL Torino 4
AOU San Luigi di Orbassano

Cappellini MD; Piga A; Perrotta S; Tartaglione I; Gianesin B; Ameri P; Merella P; Miceli R; Casale M; Longo F; Pasanisi A; Casu G; Origa R; Barella S; Giuditta M; Graziadei G; Pinto VM; Musallam KM; Derchi G; Forni GL;

Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection. in American journal of hematology / Am J Hematol. 2022 Feb 1;97(2):E75-E78. doi: 10.1002/ajh.26429. Epub 2021 Dec 10.
2022
ASL Torino 4
AOU San Luigi di Orbassano

Tartaglione I; Denotti AR; Fortini M; Borsellino Z; Quintino S; Balocco M; Ricchi P; De Giovanni A; Graziadei G; Migone De Amicis M; Gaglioti C; Serra M; Putti MC; Carrai V; Gentile M; Bagnato S; Miano M; Lisi R; De Michele E; Massa A; Campisi S; Arcioni F; Quota A; Ribersani M; Quaresima M; Pitrolo L; Bonetti F; Vitucci A; Dal Zotto C; et alii...

Long-Term Effects of Iron Chelating Agents on Ocular Function in Patients with Thalassemia Major. in Clinical ophthalmology (Auckland, N.Z.) / Clin Ophthalmol. 2021 May 20;15:2099-2109. doi: 10.2147/OPTH.S300974. eCollection 2021.
2021
AOU San Luigi di Orbassano

Caselgrandi P; Nuzzi A; Geronazzo G; Tridico F; Nuzzi R; Piga AG;

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Tamburlini G; Marchetti F; Bertino E; Bestetti G; Biasucci G; Biondi A; Bonati M; Brunelli A; Corsello G; Esposito S; Fagioli F; Farina D; Gagliardi L; Gangemi M; Greco L; Lanari M; Lazzerini M; Maggiore G; Martelossi S; Ramenghi U; Piga A; Selicorni A; Spada M; Ventura A; Vicari S; Zampino G; Zanetto F;

The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients. in The pharmacogenomics journal / Pharmacogenomics J. 2019 Oct;19(5):417-427. doi: 10.1038/s41397-019-0071-7. Epub 2019 Jan 17.
2019
AOU San Luigi di Orbassano
ASL Città di Torino

Piga A; Avataneo V; De Nicolò A; Massano D; Pirro E; Longo F; Cusato J; De Francia S; D'Avolio A; Allegra S;

Prevalence and prognostic impact of left ventricular non-compaction in patients with thalassemia. in Internal and emergency medicine / Intern Emerg Med. 2019 Nov;14(8):1299-1306. doi: 10.1007/s11739-019-02114-3. Epub 2019 Jun 25.
2019
ASL Biella
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Piga A; Limone M; Xhyheri B; Faletti R; Gatti M; Bonamini R; Longo F; Imazio M;

Current challenges in the management of patients with sickle cell disease - A report of the Italian experience. in Orphanet journal of rare diseases / Orphanet J Rare Dis. 2019 May 30;14(1):120. doi: 10.1186/s13023-019-1099-0.
2019
AOU San Luigi di Orbassano

Cappellini MD; Sainati L; Ferrara F; Casale M; Venturelli D; Sorrentino F; Ruffo GB; Pinto V; Pietrangelo A; Graziadei G; Quota A; Fidone C; Palazzi G; Voi V; Perrotta S; Rigano P; Colombatti R; De Franceschi L; Russo G; Piga A; Maggio A; Forni GL;

Dual-Energy X-ray Absorptiometry Predictors of Vertebral Deformities in Beta-Thalassemia Major. in Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry / J Clin Densitom. 2018 Oct-Dec;21(4):507-516. doi: 10.1016/j.jocd.2017.06.028. Epub 2017 Jul 27.
2018
AOU San Luigi di Orbassano

Osella G; Priola AM; Priola SM; Piga A; Longo F; Ventura M; Bentivegna G; Angeli A; Veltri A; Terzolo M;

Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes. in The pharmacogenomics journal / Pharmacogenomics J. 2018 May 22;18(3):506-515. doi: 10.1038/tpj.2017.43. Epub 2017 Nov 21.
2018
AOU San Luigi di Orbassano
ASL Città di Torino

Piga A; De Nicolò A; Massano D; Pirro E; Longo F; Arduino A; De Francia S; Cusato J; Allegra S; D'Avolio A;

Clinical relevance of deferasirox trough levels in ?-thalassemia patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2018 Feb;45(2):213-216. doi: 10.1111/1440-1681.12879. Epub 2017 Dec 4.
2018
AOU San Luigi di Orbassano
ASL Città di Torino

D'Avolio A; Cusato J; Pirro E; Piccione F; Longo F; De Francia S; Massano D; Allegra S; Piga A;

Deferasirox pharmacokinetic evaluation in ?-thalassaemia paediatric patients. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 May;69(5):525-528. doi: 10.1111/jphp.12559. Epub 2016 May 27.
2017
AOU San Luigi di Orbassano
ASL Città di Torino

D'Avolio A; Piga A; Massano D; Pirro E; De Francia S; Cusato J; Allegra S;

Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients. in Pharmacogenomics / Pharmacogenomics. 2017 Apr;18(6):539-554. doi: 10.2217/pgs-2016-0176. Epub 2017 Mar 27.
2017
AOU San Luigi di Orbassano
ASL Città di Torino

Piga A; Longo F; Massano D; Arduino A; Cusato J; De Francia S; Allegra S; D'Avolio A;

Deferasirox AUC efficacy cutoff and role of pharmacogenetics. in European journal of clinical pharmacology / Eur J Clin Pharmacol. 2016 Sep;72(9):1155-7. doi: 10.1007/s00228-016-2070-9. Epub 2016 May 18.
2016
AOU San Luigi di Orbassano

Allegra S; Cusato J; De Francia S; Massano D; Piga A; D'Avolio A;

Deferasirox pharmacokinetic and toxicity correlation in ?-thalassaemia major treatment. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2016 Nov;68(11):1417-1421. doi: 10.1111/jphp.12638. Epub 2016 Sep 27.
2016
AOU San Luigi di Orbassano

Allegra S; De Francia S; Cusato J; Pirro E; Massano D; Piga A; D'Avolio A;

Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous ?-thalassaemia. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2016 Dec;84:1510-1512. doi: 10.1016/j.biopha.2016.11.041. Epub 2016 Nov 20.
2016
AOU San Luigi di Orbassano

Allegra S; De Francia S; Longo F; Massano D; Cusato J; Arduino A; Pirro E; Piga A; D'Avolio A;

Role of pharmacogenetics on deferasirox AUC and efficacy. in Pharmacogenomics / Pharmacogenomics. 2016 Apr;17(6):561-72. doi: 10.2217/pgs-2015-0001. Epub 2016 Apr 4.
2016
AOU San Luigi di Orbassano

Cusato J; Allegra S; De Francia S; Massano D; Piga A; D'Avolio A;

Management of pulmonary arterial hypertension associated to thalassemia: when pulmonary endarterectomy is the best therapeutical option? A case report. in Journal of thrombosis and thrombolysis / J Thromb Thrombolysis. 2015 Jan;39(1):139-43. doi: 10.1007/s11239-014-1073-6.
2015
AOU San Luigi di Orbassano

Roggero S; Vullo S; Volpe G; Piga A; Albera C;

2015
AOU San Luigi di Orbassano

De Montalembert M; Abboud MR; Fiquet A; Inati A; Lebensburger JD; Kaddah N; Mokhtar G; Piga A; Halasa N; Inusa B; Rees DC; Heath PT; Telfer P; Driscoll C; Al Hajjar S; Tozzi A; Jiang Q; Emini EA; Gruber WC; Gurtman A; Scott DA;

2014
AOU San Luigi di Orbassano

Ruo Redda MG; Allis S; Reali A; Bartoncini S; Roggero S; Anglesio SM; Piga A;

A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Apr 15;893-894:127-33. doi: 10.1016/j.jchromb.20
2012
AOU San Luigi di Orbassano

De Francia S; Massano D; Piccione FM; Pirro E; Racca S; Di Carlo F; Piga A;

Exercise Stress Echocardiography with Tissue Doppler Imaging (TDI) Detects Early Systolic Dysfunction in Beta-Thalassemia Major Patients without Cardiac Iron Overload. in Mediterranean journal of hematology and infectious diseases / Mediterr J Hematol Infect Dis. 2012;4(1):e2012037. doi: 10.4084/MJHID.2012.037. Epub 2012 Jun 14.
2012
AOU San Luigi di Orbassano

Barbero U; Destefanis P; Pozzi R; Longo F; Piga A;

2010
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Vinciguerra T; Longo F; Calvo PL; Romagnoli R; Baldi M; Brunati A; Gonzalez De Requena Farre D; Carbonaro G; Pucci A; Piga A; Salizzoni M; Barbera C;

Diagnosis of juvenile hemochromatosis in an 11-year-old child combining genetic analysis and non-invasive liver iron quantitation. in European journal of pediatrics / Eur J Pediatr. 2003 Feb;162(2):96-9. doi: 10.1007/s00431-002-1114-6. Epub 2002 Dec 10.
2003
AOU San Luigi di Orbassano

De Gobbi M; Caruso R; Daraio F; Chianale F; Pinto RM; Longo F; Piga A; Camaschella C;

New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. in Blood / Blood. 2001 May 1;97(9):2555-60. doi: 10.1182/blood.v97.9.2555.
2001
AOU San Luigi di Orbassano

Roetto A; Totaro A; Piperno A; Piga A; Longo F; Garozzo G; Calì A; De Gobbi M; Gasparini P; Camaschella C;

1997
AOU San Luigi di Orbassano

Ivaldi G; Scimè-Degani V; David O; Baffico M; Baldi M; Leone D; Mazzocco M; Leone L; Piga A; Furlan E; Ricco G;